Live Nasdaq Composite: Tech Propels Broader Markets Higher on Memory Stock Strength

Health and Healthcare

Moderna : MRNA

All Moderna Articles

129 Articles

Chris Lange | Oct 2, 2020 at 11:58 AM EDT

Where We Stand on a Vaccine After Trump Catches COVID-19

President Trump and the First Lady have tested positive for COVID-19. That begs the question, now more than ever, of…

Chris Lange | Sep 30, 2020 at 9:22 AM EDT

2 Big Positive Developments in the COVID-19 Vaccine Race

Moderna and Regeneron Pharmaceuticals each announced positive news late on Tuesday about their respective COVID-19 vaccine trials.

Lee Jackson | Sep 30, 2020 at 7:42 AM EDT

4 Companies in Late-Stage Coronavirus Vaccine Testing: Will Big Pharma Win the Race?

These companies have a very good shot at crossing the finish line first with a COVID-19 vaccine. Even those that…

Chris Lange | Sep 25, 2020 at 9:54 AM EDT

Biotech Short Sellers Hike Their Bets

The September 15 short interest data has been compared with the previous report, and short interest in most of these…

Jon C. Ogg | Sep 23, 2020 at 10:48 AM EDT

The Advantage Johnson & Johnson’s Phase 3 COVID-19 Study Has Over Rivals

The race for the COVID-19 vaccine is still very much on, and Johnson & Johnson just announced the launch of…

Jon C. Ogg | Sep 8, 2020 at 3:27 PM EDT

What Does a Perfect COVID-19 Vaccine Actually Mean?

The race for finding the COVID-19 vaccine is in full swing, and it has just seen one team move ahead…

Jon C. Ogg | Sep 8, 2020 at 9:11 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Baidu, Boeing, Delta, Disney, L3Harris, Moderna, Raytheon, Roku and More

Tuesday's top analyst upgrades and downgrades include Apple, Baidu, Boeing, Delta Air Lines, L3Harris Technologies, Moderna, Raytheon Technologies, Roku and…

Jon C. Ogg | Sep 2, 2020 at 7:27 PM EDT

As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval

America and the rest of the world is getting ready for a vaccine that will help protect public health against…

Jon C. Ogg | Sep 1, 2020 at 8:46 AM EDT

3 COVID-19 Vaccine Trials Are Now in Phase 3, With More on the Way

Three U.S. COVID-19 vaccine trials are now in Phase 3 studies. All three appear to have some serious benefits, but…

Jon C. Ogg | Aug 26, 2020 at 11:21 AM EDT

Analyst Sees Moderna as Cheap Ahead of Interim COVID-19 Data

Independent research firm Argus has reiterated its Buy rating on Moderna and is calling this large pullback a buying opportunity.

Chris Lange | Aug 12, 2020 at 11:28 AM EDT

Moderna’s New Deal: Is This a Case of ‘Sell the News’?

When Moderna announced a new deal with the U.S. government for its COVID-19 vaccine, it appeared be a case of…

Jon C. Ogg | Aug 6, 2020 at 9:12 AM EDT

Top Analyst Upgrades and Downgrades: BioNTech, Costco, Enphase, Etsy, Moderna, Novavax, Regeneron, Roku, Square, Teva, Wayfair, Zynga and More

Thursday's top analyst upgrades and downgrades included Costco, Enphase Energy, Etsy, Moderna, Novavax, Regeneron Pharmaceuticals, Roku, Square, Teva Pharmaceutical, Wayfair…

Chris Lange | Jul 24, 2020 at 11:25 AM EDT

Moderna’s Pain Is Arbutus’s Gain in COVID-19 Patent Ruling

Arbutus Biopharma stock has seen an incredible rise over the past few days after the firm won a patent dispute…

Jon C. Ogg | Jul 23, 2020 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: Apache, Check Point, Chipotle, EA, Inogen, Microsoft, Moderna, Shopify, Tesla, Varonis and More

Thursday's top analyst upgrades and downgrades included Apache, Check Point Software Technologies, Chipotle Mexican Grill, Electronic Arts, Inogen, Microsoft, Moderna,…

Lee Jackson | Jul 22, 2020 at 7:28 AM EDT

4 First-Half Growth Stock Winners Are Top Picks for the Rest of 2020

These four top Jefferies growth stock picks all offer investors strength in their specific industries and the ability to generate…

1 … 5 6 7 8 9

Moderna : MRNA

All Moderna Articles

Where We Stand on a Vaccine After Trump Catches COVID-19

2 Big Positive Developments in the COVID-19 Vaccine Race

4 Companies in Late-Stage Coronavirus Vaccine Testing: Will Big Pharma Win the Race?

Biotech Short Sellers Hike Their Bets

The Advantage Johnson & Johnson’s Phase 3 COVID-19 Study Has Over Rivals

What Does a Perfect COVID-19 Vaccine Actually Mean?

Top Analyst Upgrades and Downgrades: Apple, Baidu, Boeing, Delta, Disney, L3Harris, Moderna, Raytheon, Roku and More

As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval

3 COVID-19 Vaccine Trials Are Now in Phase 3, With More on the Way

Analyst Sees Moderna as Cheap Ahead of Interim COVID-19 Data

Moderna’s New Deal: Is This a Case of ‘Sell the News’?

Top Analyst Upgrades and Downgrades: BioNTech, Costco, Enphase, Etsy, Moderna, Novavax, Regeneron, Roku, Square, Teva, Wayfair, Zynga and More

Moderna’s Pain Is Arbutus’s Gain in COVID-19 Patent Ruling

Top Analyst Upgrades and Downgrades: Apache, Check Point, Chipotle, EA, Inogen, Microsoft, Moderna, Shopify, Tesla, Varonis and More

4 First-Half Growth Stock Winners Are Top Picks for the Rest of 2020

Live Nasdaq Composite: Tech Propels Broader Markets Higher on Memory Stock Strength

Zuckerberg’s Insane AI Spending Could Become a Windfall, If Meta Copies SpaceX’s Playbook

Never Worry About Money Again: Retire to The Woodlands, Texas, at 65 on $1.1 Million

A 70-Year-Old Cashed In Her Gold Coins Near $4,000. The Collectibles Tax Was Only Half the Hit, the Gain Also Taxed Her Social Security

Never Worry About Money Again: Retire to The Woodlands, Texas, at 65 on $1.1 Million

A 70-Year-Old Cashed In Her Gold Coins Near $4,000. The Collectibles Tax Was Only Half the Hit, the Gain Also Taxed Her Social Security

Zuckerberg’s Insane AI Spending Could Become a Windfall, If Meta Copies SpaceX’s Playbook

Never Worry About Money Again: Retire to The Woodlands, Texas, at 65 on $1.1 Million

Moderna : MRNA

All Moderna Articles

Where We Stand on a Vaccine After Trump Catches COVID-19

2 Big Positive Developments in the COVID-19 Vaccine Race

4 Companies in Late-Stage Coronavirus Vaccine Testing: Will Big Pharma Win the Race?

Biotech Short Sellers Hike Their Bets

The Advantage Johnson & Johnson’s Phase 3 COVID-19 Study Has Over Rivals

What Does a Perfect COVID-19 Vaccine Actually Mean?

Top Analyst Upgrades and Downgrades: Apple, Baidu, Boeing, Delta, Disney, L3Harris, Moderna, Raytheon, Roku and More

As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval

3 COVID-19 Vaccine Trials Are Now in Phase 3, With More on the Way

Analyst Sees Moderna as Cheap Ahead of Interim COVID-19 Data

Moderna’s New Deal: Is This a Case of ‘Sell the News’?

Top Analyst Upgrades and Downgrades: BioNTech, Costco, Enphase, Etsy, Moderna, Novavax, Regeneron, Roku, Square, Teva, Wayfair, Zynga and More

Moderna’s Pain Is Arbutus’s Gain in COVID-19 Patent Ruling

Top Analyst Upgrades and Downgrades: Apache, Check Point, Chipotle, EA, Inogen, Microsoft, Moderna, Shopify, Tesla, Varonis and More

4 First-Half Growth Stock Winners Are Top Picks for the Rest of 2020

Live Nasdaq Composite: Tech Propels Broader Markets Higher on Memory Stock Strength

Zuckerberg’s Insane AI Spending Could Become a Windfall, If Meta Copies SpaceX’s Playbook

Never Worry About Money Again: Retire to The Woodlands, Texas, at 65 on $1.1 Million

A 70-Year-Old Cashed In Her Gold Coins Near $4,000. The Collectibles Tax Was Only Half the Hit, the Gain Also Taxed Her Social Security

Featured Reads

Never Worry About Money Again: Retire to The Woodlands, Texas, at 65 on $1.1 Million

A 70-Year-Old Cashed In Her Gold Coins Near $4,000. The Collectibles Tax Was Only Half the Hit, the Gain Also Taxed Her Social Security